Sarcar, Bhaswati <br/><br/>
Targeting radiation-induced G(2) checkpoint activation with the Wee-1 inhibitor MK-1775 in glioblastoma cell lines.  [electronic resource] 

 -  Molecular cancer therapeutics  Dec 2011 
 - 2405-14 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1538-8514 
<br/><br/><label>Standard No.: </label>10.1158/1535-7163.MCT-11-0469  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Brain Neoplasms--drug therapy<br/>Cell Cycle Proteins--antagonists & inhibitors<br/>Cell Line, Tumor<br/>G2 Phase Cell Cycle Checkpoints--drug effects<br/>Glioblastoma--drug therapy<br/>Humans<br/>Mice<br/>Mice, Nude<br/>Molecular Targeted Therapy<br/>Nuclear Proteins--antagonists & inhibitors<br/>Protein Kinase Inhibitors--pharmacokinetics<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Pyrazoles--pharmacokinetics<br/>Pyrimidines--pharmacokinetics<br/>Pyrimidinones<br/>Radiation Tolerance--drug effects<br/>Radiation-Sensitizing Agents--pharmacokinetics<br/>Up-Regulation--drug effects<br/>Xenograft Model Antitumor Assays